Refining Therapeutic Approaches in R/R MM: Expert Guidance on Bispecific Antibody Therapy Optimization

Gain knowledge and insights on bispecific antibody therapy optimization in R/R MM through an expert commentary, on-demand webcast, podcasts, interactive decision support tool, and downloadable slides.

Share

Program Content

Activities

BsAbs in MM
A Quick Guide to Bispecific Antibodies for the Treatment of Relapsed/Refractory Multiple Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 24, 2024

Expires: September 23, 2025

Activities

Interactive Decision Support Tool on BsAb AE Management
Point-of-Care, Digital, Interactive Decision Support Tool (IDST) for the Prevention/Management of AEs During Treatment with BsAbs in MM
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: January 06, 2025

Expires: January 05, 2026

Activities

Bispecific Antibodies in R/R MM
Relapsed/Refractory Multiple Myeloma: Role and Safety of Bispecific Antibodies
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: October 24, 2024

Expires: October 23, 2025

Faculty

cover img faculity

Caitlin Costello, MD

Clinical Professor of Medicine
Director, Multiple Myeloma Program
Division of Blood and Marrow Transplantation
Moores Cancer Center
UC San Diego
La Jolla, California

cover img faculity

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program, Case Comprehensive Cancer Center
Cleveland, Ohio

cover img faculity

Melissa Pozotrigo, PharmD, BCOP

Senior Clinical Oncology Pharmacist
OncoHealth
Atlanta, Georgia

cover img faculity

Noopur Raje, MD

Professor of Medicine
Harvard Medical School
Director, Center for Multiple Myeloma
Massachusetts General Hospital
Boston, Massachusetts

Provided by

ProCE Banner
ProCE Banner

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. Supported by a grant from Pfizer Inc. Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Pfizer, Inc.

Regeneron Pharmaceuticals, Inc